.png?width=2400&height=263&name=Emergent-BioServices_CMYK_Logo-Tagline-Lockup%20(2).png "Emergent BioSolutions CDMO"){kind=logo}
Original news coverage of Vaxart's agreement with Emergent BioSolutions to manufacture and develop an experimental oral vaccine candidate for the Coronavirus Disease.
- Washington Business Journal: Emergent BioSolutions dives into another coronavirus vaccine effort (March 18, 2020)
- Technically - Baltimore: Emergent Biosolutions will manufacture Vaxart’s experimental coronavirus vaccine in Baltimore (March 18, 2020)
- RTT News: Vaxart Joins With Emergent To Advance Experimental COVID-19 Vaccine (March 18, 2020)
- Baltimore Sun: Baltimore scientists to work on third experimental coronavirus vaccine (March 18, 2020)
- The Daily Record: Emergent BioSolutions signs 2nd COVID-19 vaccine deal (March 18, 2020)
- The Fly: Emergent BioSolutions, Vertex partner to develop oral COVID-19 vaccine (March 18, 2020)
- Market Watch: Vaxart: Emergent to manufacture Vaxart's experimental COVID-19 vaccine (March 18, 2020)
